Johns Hopkins Medicine Apr 20 2026 Scientists from Johns Hopkins Medicine report new evidence that clusters of brain tissue derived from the cells of patients with Alzheimer's disease may be used to evaluate how certain patients with the neurodegenerative condition may respond to drugs commonly prescribed to treat psychiatric symptoms of the disorder.  The findings, based on a study of lab-grown brain tissues known as organoids, contribute to a growing body of evidence that brain organoids may